) performed the statistical analysis. Local investigators (study group) and participating centers (emergency departments) are listed according to the number of patients included in the study ,
Rates of hemorrhage during warfarin therapy for atrial fibrillation, Canadian Medical Association Journal, vol.185, issue.2, pp.121-127, 2013. ,
DOI : 10.1503/cmaj.121218
Bleeding Complications With Warfarin Use, Archives of Internal Medicine, vol.167, issue.13, pp.1414-1419, 2007. ,
DOI : 10.1001/archinte.167.13.1414
Effect of Increased Warfarin Use on Warfarin-Related Cerebral Hemorrhage: A Longitudinal Population-Based Study, Stroke, vol.42, issue.9, pp.2431-2435, 2011. ,
DOI : 10.1161/STROKEAHA.111.615260
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage, Neurology, vol.63, issue.6, pp.1059-1064, 2004. ,
DOI : 10.1212/01.WNL.0000138428.40673.83
Poor Prognosis in Warfarin-Associated Intracranial Hemorrhage Despite Anticoagulation Reversal, Stroke, vol.43, issue.7, pp.1812-1817, 2012. ,
DOI : 10.1161/STROKEAHA.112.652065
Warfarin-associated Intracerebral Hemorrhage is Increasing in Prevalence in the United States, Journal of Stroke and Cerebrovascular Diseases, vol.22, issue.7, pp.1151-1155, 2013. ,
DOI : 10.1016/j.jstrokecerebrovasdis.2012.11.015
Bench-to-bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage ??? from theory to practice, Critical Care, vol.13, issue.2, p.209, 2009. ,
DOI : 10.1186/cc7701
Efficacy and Safety of a Four-Factor Prothrombin Complex Concentrate (4F-PCC) in Patients on Vitamin K Antagonists Presenting with Major Bleeding: A Randomized, Plasma-Controlled, Phase IIIb Study, Circulation, vol.128, pp.1234-1243, 2013. ,
DOI : 10.1161/CIRCULATIONAHA.113.002283
Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage, Intensive Care Medicine, vol.12, issue.4, pp.721-725, 2007. ,
DOI : 10.1007/s00134-007-0528-z
French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding), Thrombosis Research, vol.126, issue.3 ,
DOI : 10.1016/j.thromres.2010.06.017
Evidence-Based Management of Anticoagulant Therapy, Chest, vol.141, issue.2, pp.152-184, 2012. ,
DOI : 10.1378/chest.11-2295
Management of bleeding and coagulopathy following major trauma: an updated European guideline, Critical Care, vol.17, issue.2, p.76, 2013. ,
DOI : 10.1186/cc12685
New Antithrombotic Drugs, Chest, vol.141, issue.2, pp.120-151, 2012. ,
DOI : 10.1378/chest.11-2294
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement, Epidemiology, vol.18, issue.6, pp.1453-1457, 2007. ,
DOI : 10.1097/EDE.0b013e3181577654
Emergency reversal of anticoagulation: The real use of prothrombin complex concentrates, Thrombosis Research, vol.130, issue.3, pp.178-183, 2006. ,
DOI : 10.1016/j.thromres.2012.05.029
URL : https://hal.archives-ouvertes.fr/hal-00825707
Teaching improves adherence to clinical guidelines in the treatment of oral anticoagulation-related severe bleeding in the emergency department, Intensive Care Medicine, vol.164, issue.8, pp.1444-1448, 2009. ,
DOI : 10.1007/s00134-009-1465-9
Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records, Journal of Thrombosis and Haemostasis, vol.10, issue.4, pp.596-605, 2012. ,
DOI : 10.1111/j.1538-7836.2012.04636.x
Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation, Thrombosis Research, vol.122, issue.1, pp.117-123, 2008. ,
DOI : 10.1016/j.thromres.2007.09.002
study, Journal of Thrombosis and Haemostasis, vol.19, issue.7, pp.1123-1127, 2009. ,
DOI : 10.1111/j.1538-7836.2009.03435.x
URL : https://hal.archives-ouvertes.fr/hal-01242373
Intracerebral haemorrhage, The Lancet, vol.373, issue.9675, pp.1632-1644, 2009. ,
DOI : 10.1016/S0140-6736(09)60371-8
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists, Thrombosis and Haemostasis, vol.106, issue.3, pp.429-438, 2011. ,
DOI : 10.1160/TH11-01-0052
Predictors of Outcome in Warfarin-Related Intracerebral Hemorrhage, Archives of Neurology, vol.65, issue.10, pp.1320-1325, 2008. ,
DOI : 10.1001/archneur.65.10.1320
Early care limitations independently predict mortality after intracerebral hemorrhage, Neurology, vol.68, issue.20, pp.1651-1657, 2007. ,
DOI : 10.1212/01.wnl.0000261906.93238.72
Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice, Critical Care, vol.16, issue.5, p.185, 2012. ,
DOI : 10.1002/ajh.21046
URL : https://hal.archives-ouvertes.fr/hal-00825705